Triglyceride-glucose index and risk of all-cause and cardiovascular mortality in patients with cardiovascular disease: Analysis from 1999 to 2018 NHANES data
Wenlong Ding,Caoyang Fang,Long Wang,Cunming Fang
DOI: https://doi.org/10.1097/md.0000000000040534
IF: 1.6
2024-11-28
Medicine
Abstract:As aging rapidly advances, cardiovascular disease (CVD) has an increasingly significant impact on people's physical health. The occurrence and death rates of CVD are continuously increasing. [ 1 ] In 2019, there was a rise of 252 million in the amount of CVD individuals compared to 1990, leading to an increase of 6.5 million deaths, making it a predominant contributor to death. [ 2 ] Risk factors for CVD include age, gender, urine sugar, hypertension, obesity, and high cholesterol levels. [ 3 , 4 ] Despite the significant treatment progress in the last 2 decades, CVD remains a primary reason of mortality, presenting a notable risk to life. Insulin resistance (IR) is a state with diminished responsiveness and reactivity to insulin. Individuals with IR are at higher risk for metabolic issues like elevated blood sugar, abnormal blood lipids, and hypertension, all of which are closely associated with the adverse effects of CVD. Therefore, whether or not diabetes is present, IR serves as both a contributing factor and a marker for adverse outcomes in CVD patients. [ 5 , 6 ] The triglyceride-glucose (TyG) index functions as a symbol of IR, offering insights into both IR and pancreatic function, while also predicting the likelihood of developing type 2 diabetes. [ 7 , 8 ] Growing evidence indicates a correlation between the index and negative implications in individuals with CVD, [ 9 , 10 ] including heart attack, cardiac arrest, and cerebral infarction. [ 11–13 ]
medicine, general & internal